Our expertise

The UAE overhauled its pharmaceutical regulatory framework in 2025. The Emirates Drug Establishment now issues marketing authorisations and oversees drug registration, taking over functions previously handled by MOHAP. This article explains how the new system works, which authority applies in each emirate, and what pharmaceutical companies need to do to obtain and maintain market access.

The UAE’s capital markets regime changed materially on 1 January 2026 with the replacement of the SCA by the Capital Market Authority. This article explains how public offerings, private placements, and prospectus liability now work on the mainland and how the DIFC and ADGM regimes fit alongside the new framework.

The UAE's Islamic finance sector holds over AED 1 trillion in banking assets and is governed by a framework that changed materially in 2025. This article explains how the three dominant Islamic finance structures work under UAE law, which authorities regulate them, and where the legal risks sit after the Dubai Court of Cassation's binding rulings on interest prohibition.